Biologics CDMO Services: Your Biologics CDMO Partner for Life
We combine technical leadership in cell culture and microbial fermentation with world-class cGMP manufacturing facilities. Located in the United States and Europe, our flexible manufacturing strategies and end-to-end solutions provide our partners everything they need to advance their therapies to patients.
We are a leading provider of cell culture services for biologics, from early manufacturability assessments, cell line and process development through to clinical and commercial manufacturing. Explore our Apollo™ X mammalian cell line development, MaruX™ continuous manufacturing and other solutions for monoclonal antibodies (mAbs), non-mAbs, fusion proteins and multispecifics.
For a range of microbial hosts (E.coli, P. pastoris, S. cerevisiae) we create flexible, modular plans to take you from strain selection, through process development and to commercialization.
De-risk strain selection and make informed decisions based on titer and product quality using our Paveway PLUS proven expression system.
Across our global network, access unsurpassed experience in difficult-to-express proteins, potent APIs and various PEGylation / conjugation chemistries coupled with a strong regulatory track record to deliver the project you need, when you need it.
If you need to develop, scale up and manufacture using insect cell culture (ICC) and baculovirus expression vector (BEV) systems, you will find our comprehensive workflows and solutions are intentionally designed with a line of sight to commercialization. Leverage our unsurpassed industry experience in developing and commercializing multiple ICC/ BEVS therapies to achieve your program goals.
Our Facilities
